Institute of Biostructures and Bioimaging, National Research Council, Napoli, Italy.
The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, USA.
Radiother Oncol. 2022 Feb;167:219-225. doi: 10.1016/j.radonc.2021.12.038. Epub 2021 Dec 31.
To investigate the interplay between spatial dose patterns and single nucleotide polymorphisms in the development of radiation-induced lymphopenia (RIL) in 186 non-small-cell lung cancer (NSCLC) patients undergoing chemo-radiotherapy (RT).
This study included NSCLC patients enrolled in a randomized trial of protons vs. photons with available absolute lymphocyte counts at baseline and during RT and XRCC1-rs25487 genotyping data. After masking the GTV, planning CT scans and dose maps were spatially normalized to a common anatomical reference. A Voxel-Based Analysis (VBA) was performed to assess voxel-wise relationships of dosiomic and genomic explanatory variables with RIL. The underlying generalized linear model was designed to include both the explanatory variables (3D dose distributions and the XRCC1-rs25487 genotypes) and possible nuisance variables significantly correlated with RIL. The maps of model coefficients as well as their significance maps were generated.
Measures for RIL definition during RT were characterized, including kinetic parameters for lymphocyte loss. The VBA generated three-dimensional maps of correlation between RIL and dose in lymphoid organs as well as organs with abundant blood pools. The identified voxel-wise relationships account for XRCC1-rs25487 polymorphism and demonstrate the variant AA genotype being detrimental to lymphocyte depletion (p = 0.03).
The performed analyses blindly highlighted relevant anatomical regions that contributed most to lymphocyte depletion during RT and the interplay of the variant XRCC1-rs25487 AA genotype with the dose delivered to the primary lymphoid organs. These findings may help to guide the development of dosimetric RIL mitigation strategies for the application of effective individualized RT.
研究在 186 例接受放化疗(RT)的非小细胞肺癌(NSCLC)患者中,空间剂量模式与单核苷酸多态性(SNP)在放射性淋巴细胞减少症(RIL)发展中的相互作用。
本研究纳入了一项质子与光子随机对照试验的 NSCLC 患者,这些患者在基线和 RT 期间有可用的绝对淋巴细胞计数,并进行了 XRCC1-rs25487 基因分型数据。在屏蔽 GTV 后,计划 CT 扫描和剂量图被空间归一化为一个共同的解剖参考。采用基于体素的分析(VBA)来评估剂量组学和基因组学解释变量与 RIL 的体素相关性。基础的广义线性模型设计包含了解释变量(3D 剂量分布和 XRCC1-rs25487 基因型)和与 RIL 显著相关的可能干扰变量。生成了模型系数的图谱及其显著性图谱。
对 RT 期间 RIL 定义的度量进行了描述,包括淋巴细胞丢失的动力学参数。VBA 生成了 RIL 与淋巴器官和富含血液池的器官之间剂量相关性的三维图谱。确定的体素相关性解释了 XRCC1-rs25487 多态性,并表明 AA 基因型变体对淋巴细胞耗竭有不利影响(p=0.03)。
所进行的分析盲目地突出了在 RT 期间导致淋巴细胞耗竭的最相关解剖区域,以及变体 XRCC1-rs25487 AA 基因型与初级淋巴器官所接受剂量的相互作用。这些发现可能有助于指导开发用于实施有效个体化 RT 的剂量学 RIL 缓解策略。